Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?
Porto BN, Stein RT. · 2016
Read Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing? by Porto BN, Stein RT. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4983612.txt.
Introduction
Bárbara Nery Porto and Renato Tetelbom Stein review neutrophil extracellular traps in lung disease. Their review appeared in Frontiers in Immunology in 2016. Neutrophils, the most common white blood cells, can cast out webs of DNA studded with germ killing proteins. These traps, called NETs, snare microbes and stop them spreading. A histone modifying enzyme, PAD4, is a central step in trap formation. Hosts that cannot make or clear traps fall prey to infection.
Excess traps, though, injure the host. In the lung the webs spread easily through air sacs and damage tissue. Trap proteins also stir inflammation that can feed chronic disease. The authors weigh evidence across infectious and non-infectious lung conditions. Their title's question frames the balance: traps are a good defense that turns harmful in surplus. They call for treatments that trim trap excess without disarming the defense.
Catalog record
| CREATOR | Porto BN, Stein RT. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 83 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing? By Bárbara Nery Porto, Renato Tetelbom Stein Published in: Frontiers in Immunology DOI: 10.3389/fimmu.2016.00311 ABSTRACT Neutrophil extracellular traps (NETs) arise from the release of granular and nuclear contents of neutrophils in the extracellular space in response to different classes of microorganisms, soluble factors, and host molecules. NETs are composed by decondensed chromatin fibers coated with antimicrobial granular and cytoplasmic proteins, such as myeloperoxidase, neutrophil elastase (NE), and α-defensins. Besides being expressed on NET fibers, NE and MPO also regulate NET formation. Furthermore, histone deimination by peptidylarginine deiminase 4 (PAD4) is a central step to NET formation. NET formation has been widely demonstrated to be an effective mechanism to fight against invading microorganisms, as deficiency in NET release or dismantling NET backbone by bacterial DNases renders the host susceptible to infections. Therefore, the primary role of NETs is to prevent microbial dissemination, avoiding overwhelming infections. However, an excess of NET formation has a dark side. The pathogenic role of NETs has been described for many human diseases, infectious and non-infectious. The detrimental effect of excessive NET release is particularly important to lung diseases, because NETs can expand more easily in the pulmonary alveoli, causing lung injury. Moreover, NETs and its associated molecules are able to directly induce epithelial and endothelial cell death. In this regard, massive NET formation has been reported in several pulmonary diseases, including asthma, chronic obstructive pulmonary disease, cystic fibrosis, respiratory syncytial virus bronchiolitis, influenza, bacterial pneumonia, and tuberculosis, among others. Thus, NET formation must be tightly regulated in order to avoid NET-mediated tissue damage. Recent development of therapies targeting NETs in pulmonary diseases includes DNA disintegration with recombinant human DNase, neutralization of NET proteins, with anti-histone antibodies and protease inhibitors. In this review, we summarize the recent knowledge on the pathophysiological role of NETs in pulmonary diseases as well as some experimental and clinical approaches to modulate their detrimental effects. INTRODUCTION Neutrophils are key players in microbial killing, being the first immune cells to achieve the site of injury or infection (1). Therefore, neutrophils act as the first line of defense against microorganisms through phagocytosis, release of reactive oxygen species (ROS), and degranulation (2). Aside from these traditional mechanisms, neutrophils are also able to extrude DNA lattices, called neutrophil extracellular traps (NETs), which entrap and facilitate the killing of bacteria, fungi, protozoa, and even viruses (3–8). NETs are composed of decondensed chromatin fibers coated with antimicrobial proteins, such as histones, neutrophil elastase (NE), myeloperoxidase (MPO), and α-defensins (3, 7). Besides being expressed on NET fibers, NE and MPO also regulate NET formation (9). Differently, the participation of NADPH oxidase-derived ROS in NET release seems to be a matter of time of stimulation. While ROS are required to NET generation in time points beyond 1 h after stimulation (10, 11), a very rapid process (5–30 min) of NET extrusion has been reported to be ROS-independent in response to Staphylococcus aureus and Candida albicans (12, 13). Furthermore, histone deimination by peptidylarginine deiminase 4 (PAD4) is a central step to NET formation (14). Additionally, the release of these DNA threads requires autophagy and activation of p38 MAPK and the Raf-MEK-ERK signaling pathways (15–17). However, it is important to keep in mind that the specific cell components and signaling cascades may vary depending on the stimulus (18). The primary role of NETs is to prevent microbial dissemination because of its stringy structure, and to kill pathogens due to the high local concentrations of antimicrobial molecules (19). However, these attributes make NETs potentially detrimental to the host. The pathogenic role of NETs has been described for many human diseases, infectious and non-infectious (20), being particularly important to lung diseases. Netting neutrophils in the lung tissue are able to disturb microcirculation and NETs produced in the pulmonary alveoli can expand easily, filling the lungs, as is the case for cystic fibrosis (CF) (19, 21). Therefore, NET formation must be tightly regulated. In this review, we summarize the recent knowledge on the pathophysiological role of NETs in pulmonary diseases as well as some experimental and clinical approaches to modulate their detrimental effects. CYSTIC FIBROSIS Cystic fibrosis is a fatal hereditary disorder resulting from mutations in the CF transmembrane conductance regulator (CFTR) anion channel (22). This anion channel is responsible for the transport of chloride ions across the epithelial layer of the airways, which is necessary for the production of thin, freely flowing mucus. Therefore, the lungs of CF patients produce large amounts of thick mucus, leading to an obstruction of the airways and colonization by bacteria (23). Typically, CF infants are rapidly colonized by Haemophilus influenzae or S. aureus, or both. Over time, Pseudomonas aeruginosa represents the main bacterial pathogen infecting CF lungs (23, 24). Due to these frequent infections, there is a massive neutrophil infiltration to the lungs and development of chronic inflammation (25, 26). The chronic and progressive lung disease accounts for morbidity and mortality of CF patients (25). Cystic fibrosis sputum constituents include DNA, NE, MPO, and other neutrophil proteins (27), as it has been shown that bronchoalveolar lavage fluid (BAL) from CF infants presented high concentrations of DNA, which correlated with neutrophil numbers in BAL (28). However, the great amounts of extracellular DNA in CF sputum were considered to be from necrotic neutrophils and lung tissues (29). More recently, several studies have demonstrated that NETs and NET-associated proteins are present in CF sputum (30–35). Marcos and coworkers quantified free DNA levels in airway fluid from CF patients and found that those patients with poor pulmonary function presented higher levels of extracellular DNA compared to patients with mild lung disease (36), indicating that the accumulation of NET–DNA in the airways contributes to airflow obstruction in CF. Moreover, analysis of CF sputum samples revealed that elevated levels of macrophage migration inhibitory factor (MIF), a potent pro-inflammatory cytokine, correlated with poor pulmonary function, and MIF was able to induce NET formation (33). Although many of the microorganisms that colonize CF airways have been shown to induce NET formation directly (4, 6, 12, 37, 38), pro-inflammatory cytokines and neutrophil chemokines present in CF lungs are also able to stimulate NET release (30, 33), thus perpetuating the inflammation. Neutrophil recruitment and NET production in the lungs would be key events to fight against invading microorganisms, but their mission accomplishment is profoundly compromised in CF airways as patients often suffer chronic infections. Together with the failure in killing the bacteria, the excessive release of extracellular DNA accounts for biofilm formation by P. aeruginosa, and NETs act as a proinflammatory component of biofilms (39). Furthermore, over the time of infection in CF airways, P. aeruginosa is able to acquire resistance to NET-mediated killing (38), probably due to its hypermutability, a well-described mechanism for P. aeruginosa adaptation within CF lungs (40–42). In addition, it has been recently demonstrated that sub-inhibitory concentrations of LL-37, a NET component, triggers P. aeruginosa mutagenesis in chronic infections (43). Interestingly, P. aeruginosa triggers the release of the eicosanoid hepoxilin A3 by lung epithelial cells, which induces neutrophil transepithelial migration and is a natural inducer of NET formation (44, 45). Thus, the excessive release of NETs coated with proteases, together with the